Clinical characteristics of lupus enteritis in Japanese patients: the large intestine-dominant type has features of intestinal pseudo-obstruction

Lupus. 2018 Sep;27(10):1661-1669. doi: 10.1177/0961203318785770. Epub 2018 Jul 20.

Abstract

This study was performed to investigate the clinical characteristics of lupus enteritis in Japanese patients with systemic lupus erythematosus (SLE). A total of 481 patients with SLE admitted to our hospital between 2001 and 2015 were retrospectively reviewed. Diagnosis of lupus enteritis was based on the following three criteria: (1) abdominal symptoms, (2) diffuse long-segment bowel thickening and (3) a requirement for glucocorticoid therapy. Lupus enteritis was identified in 17 patients (3.5%) and there were two distinct types: small intestine-dominant and large intestine-dominant. Significant differences between the two types were noted with respect to the age, frequency of biopsy-proven lupus nephritis, frequency of rectal involvement, maximum bowel wall thickness, and requirement for steroid pulse therapy. Among patients with large intestine-dominant lupus enteritis, 60% had extra-intestinal symptoms (hydroureter, bladder wall thickening, and bile duct dilatation) that are known complications of intestinal pseudo-obstruction. Two patients with large intestine-dominant lupus enteritis developed intestinal pseudo-obstruction either before or after diagnosis of lupus enteritis. Five patients (29%) developed recurrence during a median observation period of 7.2 years (1.4-14.4 years). In conclusion, large intestine-dominant lupus enteritis resembles intestinal pseudo-obstruction and these two diseases may have a common pathogenesis.

Keywords: Cystitis; hydronephrosis; ileus; mesenteric vasculitis; systemic sclerosis.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Asian People
  • Biopsy
  • Enteritis / diagnosis*
  • Enteritis / drug therapy
  • Enteritis / epidemiology
  • Enteritis / pathology
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Incidence
  • Intestinal Pseudo-Obstruction / diagnosis*
  • Intestinal Pseudo-Obstruction / drug therapy
  • Intestinal Pseudo-Obstruction / epidemiology
  • Intestinal Pseudo-Obstruction / pathology
  • Intestine, Large / diagnostic imaging
  • Intestine, Large / drug effects
  • Intestine, Large / pathology*
  • Intestine, Small / diagnostic imaging
  • Intestine, Small / drug effects
  • Intestine, Small / pathology*
  • Japan / epidemiology
  • Lupus Erythematosus, Systemic / diagnosis*
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / epidemiology
  • Lupus Erythematosus, Systemic / pathology
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Young Adult

Substances

  • Glucocorticoids